Coronavirus COVID-19 Guidance
British Film Commission – Working Safely During COVID-19 in Film and High-end TV Drama Production
This document is intended to provide high-level guidance to manage COVID-19 specific risk in producing film and high-end TV drama in the UK.
It has been prepared in consultation with the Department for Digital, Culture Media and Sport (DCMS) with input from crew and crew representatives, industry bodies, unions and the devolved administrations in Wales, Scotland and Northern Ireland, and in consultation with Public Health England (PHE) and the Health and Safety Executive (HSE).
This guidance should be read in conjunction with the latest UK Government guidance. Productions based in Northern Ireland, Scotland and Wales should additionally check for the relevant devolved Government guidance as it may differ.
Download British Film Commission – Working Safely During COVID-19 in Film and High-end TV Drama Production guidance here.
For optimised viewing, please open the PDF through Adobe Acrobat Reader or Google Chrome. If you read the PDF using Safari or Apple Preview, links to certain sections of government guidance may not work but Apple Mac users can access an adapted version of the guidance here.
Current version: V.1.0 Published 1st June 2020
Always make sure you are working from the current version.
The UK TV industry has produced guidance for managing the risk of COVID-19 in programme making which applies to all TV production and can be found here. In the case of high-end TV drama productions, this guidance should be considered alongside the UK TV industry guidance.
Guidance for Safe Working in Post-Production and VFX, produced in consultation with, and endorsed by, the British Film Commission Recovery Group, is available here.
ScreenSkills, are adapting and developing training initiatives to support the film and HETV industries’ recovery efforts.
Read law firm Wiggin’s Returning to Production Employment and Data Protection FAQs here.
For additional industry advice and guidance on Coronavirus COVID-19, please visit: